These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31914791)

  • 1. Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis: A Systematic Review.
    de Vries JJ; Snoek CJM; Rijken DC; de Maat MPM
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):554-569. PubMed ID: 31914791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of post-translational modification of fibrinogen in the pathogenesis of thrombosis].
    Tadeusiewicz J; Nowak P
    Pol Merkur Lekarski; 2015 Feb; 38(224):107-12. PubMed ID: 25771521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.
    Hugenholtz GC; Macrae F; Adelmeijer J; Dulfer S; Porte RJ; Lisman T; Ariëns RA
    J Thromb Haemost; 2016 May; 14(5):1054-66. PubMed ID: 26833718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid.
    Moiseiwitsch N; Zwennes N; Szlam F; Sniecinski R; Brown A
    J Thromb Haemost; 2022 Dec; 20(12):2909-2920. PubMed ID: 36111490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
    Kwasny-Krochin B; Gluszko P; Undas A
    Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
    Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
    Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood clot contraction differentially modulates internal and external fibrinolysis.
    Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
    J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of fibrinogen structure in human disease.
    Hoffman M
    Cardiovasc Hematol Agents Med Chem; 2008 Jul; 6(3):206-11. PubMed ID: 18673234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals.
    Hooper JM; Stuijver DJ; Orme SM; van Zaane B; Hess K; Gerdes VE; Phoenix F; Rice P; Smith KA; Alzahrani SH; Standeven KF; Ajjan RA
    J Clin Endocrinol Metab; 2012 May; 97(5):1463-73. PubMed ID: 22378816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice.
    Ząbczyk M; Ariëns RAS; Undas A
    Cardiovasc Res; 2023 Mar; 119(1):94-111. PubMed ID: 36662542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycation and acetylation sites on fibrinogen in plasma fibrin clot of patients with type 2 diabetes: Effects of low-dose acetylsalicylic acid.
    Bryk AH; Zettl K; Wiśniewski JR; Undas A
    Thromb Res; 2021 Feb; 198():93-98. PubMed ID: 33307284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots.
    Martinez M; Weisel JW; Ischiropoulos H
    Free Radic Biol Med; 2013 Dec; 65():411-418. PubMed ID: 23851017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolaldehyde induces fibrinogen post-translational modification, delay in clotting and resistance to enzymatic digestion.
    Andrades ME; Lorenzi R; Berger M; Guimarães JA; Moreira JC; Dal-Pizzol F
    Chem Biol Interact; 2009 Aug; 180(3):478-84. PubMed ID: 19397901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombotic alterations in plasma fibrin clot properties in thyroid disorders and their post-treatment modifications.
    Mazur P; Sokołowski G; Hubalewska-Dydejczyk A; Płaczkiewicz-Jankowska E; Undas A
    Thromb Res; 2014 Aug; 134(2):510-7. PubMed ID: 24962680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
    Terasawa F; Kani S; Hongo M; Okumura N
    Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP).
    Etscheid M; Subramaniam S; Lochnit G; Zabczyk M; Undas A; Lang IM; Hanschmann KM; Kanse SM
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3397-3406. PubMed ID: 30076961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lytic Susceptibility, Structure, and Mechanical Properties of Fibrin in Systemic Lupus Erythematosus.
    Litvinov RI; Nabiullina RM; Zubairova LD; Shakurova MA; Andrianova IA; Weisel JW
    Front Immunol; 2019; 10():1626. PubMed ID: 31379831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure.
    Damiana T; Damgaard D; Sidelmann JJ; Nielsen CH; de Maat MPM; Münster AB; Palarasah Y
    Clin Chim Acta; 2020 Feb; 501():6-11. PubMed ID: 31730822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction.
    Becatti M; Marcucci R; Bruschi G; Taddei N; Bani D; Gori AM; Giusti B; Gensini GF; Abbate R; Fiorillo C
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1355-61. PubMed ID: 24790138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced plasma fibrin clot permeability and susceptibility to lysis in patients with inflammatory bowel disease: a novel prothrombotic mechanism.
    Owczarek D; Cibor D; Sałapa K; Głowacki MK; Mach T; Undas A
    Inflamm Bowel Dis; 2013 Nov; 19(12):2616-24. PubMed ID: 24108112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.